Ulcer drug has annual sales of $1.2 billion.
Lawsuit concerns patent for AstraZeneca's blockbuster Losec drug.
Molecular Devices is suing former executive who negotiated license and then left to become president of MonoGen.
Group calls the effort a "hasty, back-door attempt to stifle therapeutic cloning research."
Foreign minister Kanwal Sibal defends India's intellectual property laws amid criticism from U.S. officials and industry groups.
University had sued DRAXIS over tablet for the treatment of cognitive disorders in dogs.
New study details losses resulting from counterfeiting drugs, consumer goods and auto parts.
Suit highlights rising tensions between U.S. drugmakers and overseas biotech licensing partners over royalty payments.
Australian biotech company remains in dispute with Applera.
Transactions are expected to grow sharply as Chinese drugmakers eye domestic and Asian markets.
Quietly submitted appropriations language would ban patents on human embryos.
Transonic is represented by Knobbe, Martens, Olson & Bear.
Taxol users have another three months to file claims in case involving patent abuse.
Congress mulls "draft legislative history language" that would blur jurisdictions over declaratory judgment motions, lobbying group claims.
Unusual case concerns different requirements the FDA uses to determine first-filer status between original and amended ANDAs.
Lawsuit concerns patent for a biodegradable high molecular polymer excipient.
Oasis to stop making and selling blades for Hansatome microkeratome, license technology from Bausch & Lomb.
Roche says lawsuit is just another chapter in long-standing patent dispute.
Government says it never threatened to strip drug's patents, but won't rule out making generic versions of other new anti-HIV drugs.
MDS is seeking an injunction and an unspecified award of damages.